PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Organ Dysfunction Varies Widely in Preterm Late-Onset Bacteremia

neonatal sepsislate-onset bacteremiapreterm infantsnSOFAorgan dysfunctioncoagulase-negative staphylococciantibiotic stewardshipcohort studyNICUsepsis definitions Clinical Pharmacy Practice

Background Information

Preterm infants show diverse organ dysfunction patterns during late-onset bacteremia.

Understanding organ dysfunction variability in preterm infants with late-onset bacteremia can enhance neonatal sepsis management beyond binary classifications. In 221 preterm infants, organ dysfunction showed substantial variability, with a median maximum Neonatal Sequential Organ Failure Assessment (nSOFA) score of 6 (IQR, 1-9) for Gram-negative and 3 (IQR, 0-9) for Gram-positive bacteremia. This study highlights the limitations of relying solely on binary microbiologic criteria, suggesting a need for more nuanced frameworks to assess neonatal sepsis outcomes effectively. Neonatal sepsis management benefits from understanding the heterogeneity in organ dysfunction beyond binary pathogen classifications.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Liu S, Missigman E, Al Gharaibeh FN, Park WY, Lawler B, Kuiper JR, Makker K, Moreira AG, Wynn JL, Aziz KB

Citation: Liu S, Missigman E, Al Gharaibeh FN, et al. Heterogeneity of Critical Organ Dysfunction During Late-Onset Bacteremia in Preterm Infants. JAMA network open. 2026;9(9):e2632792. doi:10.1001/jamanetworkopen.2026.32792

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.